The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 27,801–27,900 of 31,469
Shetty, H. (2014) · International Blood Research & Reviews · doi:10.9734/ibrr/2014/8833 · Cited by 1
Does Thyroid Volume and Nodule Formation Increase in Patients with Euthyroid Metabolic Syndrome?
Usluoğulları, C. A. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000133 · Cited by 1
Wang, Y., Wang, Yan, Li, Fang, Xü, Yanqiu, Jing, Wu, Guiyan, et al. (2015) · Chin J Reprod Contracep · doi:10.7669/j.issn.1001-7844.2015.04.0213 · Cited by 1
Metabolic Syndrome and Decreased Estimated Glomerular Filtration Rate in Relation to Muscle Mass
Lee, K. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0017 · Cited by 1
Clinical Implication of Insulin Resistance in Chronic Hepatitis C Patients
Ogawa, E. (2015) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.89.1 · Cited by 1
Putera, B. W., Sartika, C. R., & Wijaya, A. (2012) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v4i1.161 · Cited by 1
Son, W., Kim, D., Sung, K.-D., et al. (2015) · Journal of the Korea Academia-Industrial cooperation Society · doi:10.5762/kais.2015.16.11.7524 · Cited by 1
The association of sex hormones and the metabolic syndrome in apparently healthy Korean male adults
김석, 이은정, 석효선, 최영길, 정원길, 이도영, 김세연, 정찬희, 박철영, Lee, W., et al. (2007) · The Korean Journal of Internal Medicine · Cited by 1
Comment évaluer la sensibilité à l’insuline chez l’homme ?
Bouché, C., Fetita, L.-S., & Gautier, J. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)74748-0 · Cited by 1
Effects of Sibutramine on Insulin Resistance, Metabolic Parameters and Abdominal Fat Mass
Fenkçi, S. M., Rota, S., Sabir, N., Yaylalı, G. F., & Sermez, Y. (2007) · Turkiye Klinikleri Tip Bilimleri Dergisi · Cited by 1
Association of carotid atherosclerosis and obesity in type 2 diabetic patients
Kang, S. H., Kim, K. M., Cho, D. H., et al. (2006) · The Korean Journal of Internal Medicine · Cited by 1
Stężenie 25-hydroksywitaminy D (25-OH-D) u otyłych nastolatków
Garanty‐Bogacka, B., Góral, J., Krupa, B., et al. (2011) · Cited by 1
Plasminogen Activator Inhibitor-1, Body Fat and Insulin Action in Aging Women.
McMillin, S. L., & Ryan, A. S. (2014) · PubMed · Cited by 1
이인녕, Chang-Hyun, J., kim, S. Y., 조봉오, & 정균근 (2014) · Exercise Science · doi:10.15857/ksep.2014.23.4.365 · Cited by 1
Eckner, J. (2014) · Cited by 1
Islamova, K. F., Petrenko, Y. V., IVANOV, D. O., et al. (2014) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2014.7(6).32-38 · Cited by 1
Pradat, P., Durant, J., Brochier, C., Trabaud, M., Cottalorda, J., Izopet, J., Raffi, F., Lucht, F., Gagnieu, M., Gatey, C., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw273 · Cited by 1
Insulin resistance and cardiometabolic risk
(2007) · CRC Press eBooks · doi:10.3109/9781420026481-3 · Cited by 1
Tokuno-Takamiya, Y., & Homma, T. (2001) · The Japanese Journal of Nutrition and Dietetics · doi:10.5264/eiyogakuzashi.59.277 · Cited by 1
Mohammed, A. K., & Khazaal, F. A. K. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20163119 · Cited by 1
Hirasawa, Y., & Umemoto, Y. (2016) · Rigakuryoho Kagaku · doi:10.1589/rika.31.399 · Cited by 1
A Comparison Between Job Stress and Insulin Resistance Among the Hospital Medical Staff
Zareian, P., Ghasemi, F., Abtahi, S. R., & Behzadi, S. (2016) · Journal of Archives in Military Medicine · doi:10.5812/jamm.37872 · Cited by 1
Xi, W., Du, X., Han, H., & Lu, X. (2016) · doi:10.7669/j.issn.1001-7844.2016.02.0094 · Cited by 1
Ogurtsov, P. P., & Kukhareva, E. I. (2016) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2016-94-3-224-230 · Cited by 1
Xiao, H. (2014) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000134 · Cited by 1
SEX HORMONE-BINDING GLOBULIN IN OBESE TYPE 2 DIABETES MELLITUS.
Mohamed, R. A. E., Maghrabya, H., Salam., E., & Mohamed, N. (2016) · International Journal of Advanced Research · doi:10.21474/ijar01/1453 · Cited by 1
Ostrem, J. D., Evanoff, N. G., Ryder, J. R., et al. (2016) · Journal of Clinical Ultrasound · doi:10.1002/jcu.22387 · Cited by 1
Advancing Islet Transplantation: From Donor to Engraftment
Sabek, O. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45433-7_10 · Cited by 1
Chronic HCV Infection Affects Cardiac Mass in Normotensives
Perticone, M., Miceli, S., Raffaele, M., et al. (2014) · Cited by 1
Role of ghrelin and adiponectin in pathogenesis of polycystic ovary syndrome, effect of metformin
El-Nahas, M., Mahmoud, H. A., Abdulla, M. M., et al. (2016) · Evidence Based Women s Health Journal · doi:10.1097/01.ebx.0000431019.80876.7a · Cited by 1
Sánchez‐López, M., Salcedo‐Aguilar, F., Solera-Martínez, M., et al. (2014) · Revista Internacional de Medicina y Ciencias de la Actividad Física y del Deporte · Cited by 1
Association of Thyroid Function with Obesity Measured as Body Fat Percentage and Insulin Resistance
Gulı́as-Herrero, A. (2016) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2016.03.00067 · Cited by 1
Hwang, H. R., Jeong, D.-W., Kim, Y. J., Lee, S.-Y., Lee, J. G., Kang, Y. H., Yi, Y.-H., Cho, Y. H., Tak, Y. J., & Zo, A. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0543-0 · Cited by 1
Do TSH Levels in Euthyroid Patients have an Impact on the Prevalence of Metabolic Syndrome
Balkan, F., Usluogullari, A. C., & Üçler, R. (2015) · Endocrinology research and practice. · doi:10.4274/tjem.2610 · Cited by 1
Esefeld, K., Halle, M., & Blair, S. N. (2011) · mediaTUM (Technical University of Munich) · Cited by 1
Li, Y., Shi, J., Huang, X., Wang, R., Gu, B., Liang, P., Zhao, S., Sun, Y., Liu, W., Deng, Y., et al. (2017) · Medical Science Monitor · doi:10.12659/msm.902450 · Cited by 1
Metabolic effects of exercise in adolescent obesity
van der Heijden, G. (2010) · Cited by 1
Valderhaug, T. G., Sharma, A., Kravdal, G., Rønningen, R., & Nermoen, I. (2017) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2017.1347958 · Cited by 1
Shin, Y., Park, J., Won, S., et al. (2017) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2017.6.1.29 · Cited by 1
Takaya, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_61-1 · Cited by 1
(2017) · International journal of research studies in biosciences · doi:10.20431/2349-0365.0509004 · Cited by 1
C-Reactive Protein Levels in Women with Polycystic Ovarian Syndrome and Healthy Controls
Yılmaz, Ö., Temür, M., Küme, T., Karas, Ç. A., Kelekçi, S., & Öztürk, Y. K. (2017) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.359835 · Cited by 1
Jung, W., Cho, H.-S., & Lee, M.-G. (2017) · Korean Journal of Sport Science · doi:10.24985/kjss.2017.28.4.808 · Cited by 1
Liver carbohydrates metabolism: A new islet-neogenesis associated protein peptide (INGAP-PP) target
Villagarcía, H. G., Román, C. L., Castro, M. C., et al. (2018) · Peptides · doi:10.1016/j.peptides.2018.01.001 · Cited by 1
Fulghesu, A. M., & Magnini, R. (2012) · InTech eBooks · doi:10.5772/28401 · Cited by 1
Gu, N., Ma, X., Zhang, J., et al. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6590532 · Cited by 1
Кононенко, Н. М., Чікіткіна, В. В., Sorokyna, M. V., et al. (2018) · News of pharmacy · doi:10.24959/nphj.18.2200 · Cited by 1
Uçan, B., Kebapçı, N., Uslu, S., Kara, M., Akçar, N., & Öner, S. (2018) · Ortadoğu Tıp Dergisi · doi:10.21601/ortadogutipdergisi.364345 · Cited by 1
Siméon, S., Massy, Z. A., Højlund, K., Lalic, K. S., Porcellati, F., Dekker, J., Petrie, J. R., Currie, G. E., & Balkau, B. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0918-1 · Cited by 1
Matia‐García, I., Salgado-Goytia, L., Ramos-Arellano, L. E., Muñóz-Valle, J. F., Armenta-Solís, A., Garibay‐Cerdenares, O. L., Ramı́rez, M., & Parra‐Rojas, I. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000012 · Cited by 1
Vitamin D Receptor Gene Polymorphism Taq in Egyptian Women With Polycystic Ovary Syndrome
Gayed, E. M. A. E., & Gayed, A. A. E. (2018) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2018.8099 · Cited by 1
Alterations of Glucose Metabolism in HIV-Infected Patients
Luna, M. I. (2018) · Current Tropical Medicine Reports · doi:10.1007/s40475-018-0154-6 · Cited by 1
Al-Dahr, M. H. S. (2018) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2018.06.00176 · Cited by 1
Corres, P., Maldonado‐Martín, S., Gorostegi-Anduaga, I., Fryer, S. M., Jurio-Iriarte, B., Aguirre-Betolaza, A. M., Arratibel-Imaz, I., Francisco-Terreros, S., & Pérez-Asenjo, J. (2018) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2018.1531297 · Cited by 1
Motamed, S., Nikooyeh, B., & Neyestani, T. R. (2018) · Nutrition and Food Sciences Research · doi:10.29252/nfsr.5.3.3 · Cited by 1
ARTICULAÇÃO EXTENSÃO E PESQUISA NO TRATAMENTO DA SÍNDROME METABÓLICA: RELATO DE EXPERIÊNCIA
Silva, C. F., Meira, D. D. S., Silva, J. M., Rossi, T. R. A., dos Santos, L. A., & Araújo, E. M. Q. (2018) · Revista UFG · doi:10.5216/revufg.v17i20.51745 · Cited by 1
Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) Protocol PH 200
DiMauro, S., Geffner, M. E., Gerschenson, M., et al. (2010) · Cited by 1
Abdul-Aziz, M. M., & Helal, N. N. (2008) · The Medical Journal of Tikrit University · Cited by 1
Özer, G., Adıgüzel, H., Kırmacı, Z. İ. K., et al. (2019) · Journal of Surgery and Medicine · doi:10.28982/josam.521927 · Cited by 1
Takahi, Y., Miyashita, K., Takahara, M., Katakami, N., Kuroda, A., Matsuoka, T., Matsuhisa, M., Ito, T., & Shimomura, I. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0180 · Cited by 1
Kandeel, H. T., Sayed, D. H. M. E., & Ahmed, E. H. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.52406 · Cited by 1
Soliman, S. E.-S., Gayed, E. M. A. E., & Gayed, A. M. A. E. (2019) · Meta Gene · doi:10.1016/j.mgene.2019.100638 · Cited by 1
Ali, D. M. M., Ali, H. A., & Rufaie, M. M.-A. (2019) · Acta Chemica Iasi · doi:10.2478/achi-2019-0014 · Cited by 1
EFFECT OF SALT LOADING ON METABOLIC CHANGES IN OVARIECTOMIZED RATS
Saleh, H. A., Saad, D. A., Abou-Bakr, D. A., Elkhateb, L. A., & Ahmed, M. A. (2020) · Al-Azhar Medical Journal · doi:10.21608/amj.2020.67555 · Cited by 1
Nagaraju, R., Joshi, A. K. R., Vamadeva, S. G., et al. (2019) · Interdisciplinary Toxicology · doi:10.2478/intox-2019-0015 · Cited by 1
Alagebrium Mitigates Metabolic Insults in High Carbohydrate and High Fat Diet Fed Wistar Rats
Hassan, S., Moustafa, A., Kabil, S. L., & Mahmoud, N. M. (2020) · Pharmaceutical Sciences · doi:10.34172/ps.2019.66 · Cited by 1
Guedes, M. R., Pontes, K. S. D. S., Valença, D., Oigman, W., Neves, M. F., & Klein, M. R. S. T. (2020) · Artery Research · doi:10.2991/artres.k.200429.001 · Cited by 1
Mengen, E., & Uçaktürk, S. A. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0016 · Cited by 3
Abozeid, A. A. (2019) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2019.89764 · Cited by 1
Lee, J. Y., Lee, S. R., & Lee, S. Y. (2020) · Medical Principles and Practice · doi:10.1159/000508876 · Cited by 1
Demirbaş, N., & Kutlu, R. (2020) · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · doi:10.5222/bmj.2020.32032 · Cited by 1
Yao, J., Kovalik, J., Lai, O. F., Lee, P. C., Eng, A. K. H., Chan, W. H., Lim, E. K. W., Bee, Y. M., & Tan, H. C. (2020) · Proceedings of Singapore Healthcare · doi:10.1177/2010105820952489 · Cited by 2
Preliminary evidence of insulin resistance in young adults with impaired sleep
Coombe, A. H., Hayat, M. J., Faulkner, M. S., Rogers, A. E., Lee, J., & Clark, P. C. (2020) · Journal of American College Health · doi:10.1080/07448481.2020.1819290 · Cited by 1
Low-cost Immobilized Enzyme Glucose Sensor based on Laminar Flow
Qiyang, X., Changbo, L., & Hoshing, W. (2020) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1681/1/012008 · Cited by 1
Hernández‐Rodas, M. C., Rojas, P., Fernando Carrasco, N., Basfi-fer, K., Codoceo, J., Inostroza, J., & Manuel Ruz, O. (2020) · Revista chilena de nutrición · doi:10.4067/s0717-75182020000601000 · Cited by 1
El-Mehiry, H. F. (2017) · مجلة بحوث التربية النوعية · doi:10.21608/mbse.2017.139075 · Cited by 1
Younus, D. A., Mustafa, S. A., Abdullah, L. Y., et al. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-00921-z · Cited by 1
Liver and Gallbladder Disease in Diabetes
Ruhl, C. E., Clark, J. M., & Everhart, J. E. (2018) · Europe PMC (PubMed Central) · Cited by 2
Mirzaei, A., Asal, A. E. A., Seidkhani‐Nahal, A., et al. (2021) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-210538 · Cited by 1
Azizi, R., Mohammadi, A., & Khajehlandi, A. (2020) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
HanXiuqin, Y. T., Lv, S., & Ji, X. Z. Z. (2013) · Cited by 1
Elevated Levels of Serum Ferritin May be Related to Non-Alcoholic Steatohepatitis
Helaly, M. A.-H., Hatata, E.-S. Z., Abdel‐Khalek, E. E., & Aal, I. A. A. (2011) · European Journal of Basic Medical Sciences · doi:10.21601/ejbms/9162 · Cited by 1
Rezaee, R., Mohebbi, M., Afkhamizadeh, M., Yaghoubi, M. A., Hoseinzadeh, M., Najafi, M. N., & Sahebkar, A. (2021) · Current Drug Safety · doi:10.2174/1574886316666210525102230 · Cited by 1
Bedair, R. N., Magour, G. M., Ooda, S. A., Amar, E. M., & Awad, A. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-020-00066-4 · Cited by 1
Vigna, L., Lonati, C., Tirelli, A. S., et al. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1902879 · Cited by 1
Keskin, M. Z., Kurtoğlu, S., Kendırcı, M., & Atabek, M. E. (2013) · Cited by 1
Relationship between Poor Sleep Quality and High White Blood Cell Count in Korean Adults
Park, J. M., & Lee, J. (2021) · Chronobiology in Medicine · doi:10.33069/cim.2021.0011 · Cited by 1
Metabolik Sendromlu Olmayan Hastalarda Non-Alkolik Yağlı Karaciğer Hastalığı
CANITEZ, V. B., Güney, İ., & Erkuş, E. (2021) · Medical Journal of Western Black Sea · doi:10.29058/mjwbs.811398 · Cited by 1
Ganeva, S., Rayanova, G. H., Todorova, K. N., Lukanov, T. H., & Blazheva, S. O. (2021) · Journal of Biomedical and Clinical Research · doi:10.2478/jbcr-2021-0012 · Cited by 2
Insulin Resistance Associated Acne
Kubba, R. (2021) · Updates in clinical dermatology · doi:10.1007/978-3-030-68996-4_9 · Cited by 1
Koca, S. B., & Bükülmez, A. (2021) · Health Sciences Quarterly · doi:10.26900/hsq.1.3.05 · Cited by 1
Schulze, A. T. V., van der Merwe, M., Touchberry, C. D., & Bloomer, R. J. (2021) · Recent Progress in Nutrition · doi:10.21926/rpn.2104001 · Cited by 1
Park, J. Y., Yoo, M., Yun, J. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01399-9 · Cited by 1
Hossain, M. M., Paul, S., Das, M., et al. (2021) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2021.09.013 · Cited by 1
Insulin Resistance and Homeostatic Model Assessment in Critically Ill: Where do We Stand?
Shah, J. N. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24059 · Cited by 1
Izaola-Jáuregui, O., Primo, D., Gómez, J. J. L., & de Luis, D. A. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.08.017 · Cited by 1
Moriyama, K., Takahashi, E., Negami, M., & Otsuka, H. (2012) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock.27.547 · Cited by 1
Zolton, J. R., Sjaarda, L. A., Mumford, S. L., Holland, T. L., Kim, K., Flannagan, K. S. J., Yisahak, S. F., Hinkle, S. N., Connell, M. T., White, M. V., et al. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.01.002 · Cited by 2
Zainab, A., Mago, A., Mehmood, A., Riad, M., & Sonavane, S. R. (2022) · National Journal of Health Sciences · doi:10.21089/njhs.62.0075 · Cited by 2
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
